November 13 from 12:30 pm – 1:15 pm PST
Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.
Please join expert rheumatologist Elizabeth Volkmann, MD and expert pulmonologist Chidinma Chima-Melton, MD, MBA as they speak with Dale S., a patient diagnosed with myositis-associated interstitial lung disease (ILD). Dale will discuss the symptoms that prompted her to see a doctor, the hurdles she had to overcome before being referred to a specialist, and how her diagnosis was finally confirmed.
Dale and the experts will discuss how recognizing the symptoms early and seeking medical attention promptly can improve outcomes for patients. The presentation will highlight the importance of collaborative care between pulmonologists and rheumatologists in diagnosing and co-managing patients with autoimmune-associated ILDs. Dale’s journey to diagnosis and the candid discussion with the experts will provide valuable insights into the challenges that patients with ILD face and the importance of working together to optimize patient care.
This program is developed and offered by Boehringer Ingelheim Pharmaceuticals, Inc. This is not an official program of the American College of Rheumatology. This is a non-CME event and does not qualify for CME, CE, or MOC credit. Presentation content has been reviewed for consistency with FDA guidelines. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals. Attendance by healthcare professionals’ spouses or guests is not permitted.
Chidinma Chima-Melton, MD, MBA
UCLA Health System
Division of Pulmonary & Critical Care Medicine
Assistant Clinical Professor
Elizabeth Volkmann, MD
David Geffen School of Medicine at University of California
Division of Rheumatology
Los Angeles, California